Loading...
XSHG600186
Market cap1.16bUSD
Jan 09, Last price  
4.93CNY
1D
-4.76%
1Q
26.32%
Jan 2017
-6.61%
Name

Lotus Health Group Co

Chart & Performance

D1W1MN
XSHG:600186 chart
P/E
67.36
P/S
4.17
EPS
0.07
Div Yield, %
0.00%
Shrs. gr., 5y
6.02%
Rev. gr., 5y
3.97%
Revenues
2.10b
+24.23%
952,165,2221,337,548,7981,855,718,8092,215,126,3642,051,068,3852,478,626,9312,697,881,2652,762,371,7872,542,826,8672,156,618,6062,004,938,7731,776,275,4221,766,772,7301,852,912,2381,728,816,9621,702,510,4151,654,638,5891,814,929,6081,691,055,1722,100,722,964
Net income
130m
+181.26%
4,604,9559,724,12521,359,43200186,595,99317,584,517036,570,829023,869,487065,247,4480028,059,63874,286,13844,364,37046,194,706129,927,433
CFO
74m
+34.66%
083,191,50223,101,69925,822,782066,524,70766,503,97814,415,21327,850,76171,161,56705,151,676000-95,910,673070,048,79454,967,20674,020,658
Dividend
Jul 11, 20020.3 CNY/sh
Earnings
May 21, 2025

Profile

Lotus Health Group Company engages in the production and sale of healthy condiments and foods in China. The company offers louts mono sodium glutamate, starch/potato/corn, and chicken bouillon. It also provides healthy oil, energy drink, healthy snack, flour, rice, and pasta products. The company was formerly known as Lotus Health Industry Holding Group Company. Lotus Health Group Company was founded in 1983 and is based in Xiangcheng, China.
URL
http://www.mylotushealth.com
IPO date
Aug 25, 1998
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
2,100,723
24.23%
1,691,055
-6.83%
Cost of revenue
1,891,583
1,554,005
Unusual Expense (Income)
NOPBT
209,140
137,050
NOPBT Margin
9.96%
8.10%
Operating Taxes
40,116
13,417
Tax Rate
19.18%
9.79%
NOPAT
169,024
123,633
Net income
129,927
181.26%
46,195
4.13%
Dividends
Dividend yield
Proceeds from repurchase of equity
2,966
(20,000)
BB yield
-0.03%
0.41%
Debt
Debt current
60,062
20,000
Long-term debt
35,598
3,146
Deferred revenue
1
(362)
Other long-term liabilities
6,202
18,519
Net debt
(1,228,168)
(1,365,985)
Cash flow
Cash from operating activities
74,021
54,967
CAPEX
(110,146)
Cash from investing activities
(130,196)
Cash from financing activities
72,698
FCF
76,790
122,171
Balance
Cash
1,252,764
1,379,971
Long term investments
71,063
9,161
Excess cash
1,218,791
1,304,579
Stockholders' equity
497,999
1,878,241
Invested Capital
932,157
(96,055)
ROIC
40.43%
44.11%
ROCE
14.62%
11.34%
EV
Common stock shares outstanding
1,856,106
1,778,418
Price
6.05
123.25%
2.71
-9.97%
Market cap
11,229,442
133.00%
4,819,513
8.27%
EV
10,001,275
3,453,527
EBITDA
225,508
155,349
EV/EBITDA
44.35
22.23
Interest
1,075
5,094
Interest/NOPBT
0.51%
3.72%